Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermediate-dose anticoagulation and atorvastatin in critically-ill COVID-19 patients
NCT04486508Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin, atorvastatin in coronavirus disease 2019 (COVID-19), sponsored by Rajaie Cardiovascular Medical and Research Center. Started Jul 2020; status: completed.
02
Drugs
enoxaparinatorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04486508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04486508.